Academic Paper: Assessment of Suicidal Risk in a Patient
Assessment of Suicidal Risk in a Patient
One of the indicators used to access the efficacy of drugs is the assessment of suicidal risk in a patient. Most patients suffering from severe depression are at risk of suicidal attempts, which is increased if TCAs are taken in high doses compared to non-cyclic drugs. Suicidal risk should, therefore, be monitored from the beginning of treatment and repeatedly throughout the treatment.
This suicidal risk factor with TCAs influences the drug choice for individuals. It is mainly the preferred choice of drug for admitted patients since they can easily be monitored constantly. Many researchers have argued on the value of using some clinical features to determine the efficacy of antidepressants and psychotherapy. Clinical variables such as age, duration of the disorder, number prior treatments, age gender, marital status, or comorbidity are some of the features that can be used to determine the efficacy of methods of treatments for depression. Comorbidity is associated to other medical conditions such as diabetes, coronary heart disease, stroke, Parkinson’s disease among others which contributes to the poor response of treatment (Duval, Lebowitz, Macher, 2006).
To acquire custom writing services, place an order to buy a Custom Academic Paper on Assessment of Suicidal Risk in a Patient.